Doctors Man Global

Doctors Man is a Japanese life sciences company specializing in the development and application of hydrogen health science. The company manufactures medical-grade hydrogen gas inhalation systems and hydrogen-rich water generators for clinical, commercial, and consumer markets. Their research focuses on the therapeutic potential of molecular hydrogen as a selective antioxidant to combat oxidative stress and inflammation. Doctors Man is a key participant in the HYBRID clinical trial, which evaluates the efficacy of hydrogen gas inhalation in improving outcomes for patients with post-cardiac arrest syndrome. The company's products are utilized in various settings, including hospitals, research institutions, and professional sports facilities.